| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |